Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LNSR
#3130
LENSAR, Inc. Common Stock
11.9
7
-0.66%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.66%
Monthly Change
-3.86%
6 month change
-1.89%
Year Change
+7.55%
Previous Close
12.0
5
Open
11.9
7
Bid
Ask
Low
11.9
7
High
11.9
7
Volume
17
Markets
US Stock Market
Healthcare
LNSR
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
TTM
Cash from operating activities
13.79 M
8.97 M
14.86 M
9.66 M
2.27 M
11.79 M
Cash from investing activities
326 K
354 K
115 K
4.16 M
2.16 M
969 K
Cash from financing activities
50 M
361 K
1.99 M
19.76 M
78 K
9.77 M
Free cash flow
13.43 M
8.62 M
14.74 M
9.42 M
2.12 M
11.71 M
News
LENSAR-Alcon deal closing pushed to first half of 2026
Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid (NASDAQ:LNSR)
LENSAR earnings missed by $0.26, revenue fell short of estimates
LENSAR earnings missed by $0.08, revenue fell short of estimates
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Alcon (NYSE:ALC)
Alcon: A Clear Vision, But Fully Valued (NYSE:ALC)
Alcon Eyes Surgical Edge With LENSAR Buyout: Details - LENSAR (NASDAQ:LNSR), Alcon (NYSE:ALC)
LENSAR stock surges 23.7% as Q4 revenue beats estimates